Figure 1.

The expression levels of MALAT1 and THRIL in patients, controls on days 1, 3, and 5 after stroke A and B: Independent Student’s t-test revealed that MALAT1 and THRIL expressions were significantly higher in patients with ischemic stroke (IS) relative to controls on days 1, 3, and 5 after stroke; C and D: The comparison of blood levels of MALAT1 and THRIL in large-artery atherosclerosis (LAA) and small-vessel disease (SVD) Results were expressed as mean ± standard error of the mean (SEM)

^**P < 0.010; ^***P < 0.001